Evaluation of Human Leucocyte Antigen (HLA) and Immunological Markers in Iraqi Associations between Family History and BMI in Celiac Disease Patients
Downloads
Objective : Celiac disease (CD) is a chronic gastrointestinal disorder of immune-mediated pathogenesis that occurs in genetically susceptible individuals due to gluten. The most important genetic factors influencing susceptibility are the molecules called Human Leukocyte Antigen (HLA). In Iraq, there is a lack of data on celiac disease patients, which is needed to provide a complete picture of the condition. Details including their family history, body mass index (BMI), nutritional deficiencies, serological markers, and HLA status are among these data.
Aim: The purpose of this study is to investigate the immunological markers and the frequency of positivity for HLA risk in Iraqi patients with celiac disease. Levels of endomysial antibody (EMA-IgA), anti-tTG IgA and anti-DGP IgG were investigated as well as their correlations with BMI, dietary factors and family history. Material and methods: Eighty Iraqis took part in this prospective case-control study, forty of them had celiac disease and forty served as healthy controls. HLA molecules were typed by PCR-SSP. The serological biomarkers were measured by Elisa and indirect immunofluorescence. Various dietary and hemostatic factors were assessed. Extensive records were kept on medical history and BMI estimates.
Results: Demonstrated that the frequency of HLA risk allele positivity was significantly higher in celiac patients (85.0% vs. 25.0%; OR = 16.3, p<0.001). EMA-IgA positive was more common (80% vs. 5%), anti-DGP IgG levels were significantly lower (98.4 ± 28.6 vs. 6.2 ± 2.1 U/mL) and anti-tTG IgA levels were significantly higher (142.6 ± 38.4 vs. 4.8 ± 1.6 U/mL). All of these findings were statistically significant (p<0.001). The BMI of the patients was significantly lower (18.6 ± 3.2 kg/m² vs. 22.4 ± 3.6 kg/m²; p<0.001) and it had an inverse relationship with anti-tTG IgA (r = −0.62, p<0.001).
Conclusions: There was a definite deficiency of iron, folate, vitamin B12, and hemoglobin. A positive family history was detected in 42.5% of patients and was related to increased HLA positivity and greater serological markers. Iraqi celiac disease is characterized by very low diagnosis rates, a strong inverse correlation between body mass index and nutritional deficiencies, and high immunological .
[1] L. M. Sollid and B. Jabri, ‘Triggers and drivers of autoimmunity: lessons from coeliac disease’, Nature Reviews Immunology, vol. 13, no. 4, pp. 294–302, 2013, doi: 10.1038/nri3407.
[2] C. Dube, A. Rostom, and R. Sy, ‘The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review’, Gastroenterology, vol. 128, no. 4 Suppl 1, pp. S57–S67, 2005, doi: 10.1053/j.gastro.2005.02.014.
[3] C. Catassi, S. Gatti, and A. Fasano, ‘The new epidemiology of celiac disease’, Journal of Pediatric Gastroenterology and Nutrition, vol. 59, no. Suppl 1, pp. S7–S9, 2014, doi: 10.1097/01.mpg.0000450393.23156.59.
[4] J. Y. Kang, A. H. Kang, A. Green, K. A. Gwee, and K. Y. Ho, ‘Systematic review: worldwide variation in the frequency of coeliac disease and changes over time’, Alimentary Pharmacology & Therapeutics, vol. 38, no. 3, pp. 226–245, 2013, doi: 10.1111/apt.12373.
[5] P. Collin, M. Mäki, O. Keyriläinen, O. Hällström, T. Reunala, and A. Pasternack, ‘Selective IgA deficiency and coeliac disease’, Scandinavian Journal of Gastroenterology, vol. 27, no. 5, pp. 367–371, 1992, doi: 10.3109/00365529209000089.
[6] J. E. Gudjonsson and J. T. Elder, ‘Psoriasis: epidemiology’, Clinics in Dermatology, vol. 25, no. 6, pp. 535–546, 2007, doi: 10.1016/j.clindermatol.2007.08.007.
[7] P. C. Dubois, G. Trynka, and L. Franke, ‘Multiple common variants for celiac disease influencing immune gene expression’, Nature Genetics, vol. 42, no. 4, pp. 295–302, 2010, doi: 10.1038/ng.543.
[8] S. Husby, S. Koletzko, and I. Korponay-Szabó, ‘European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020’, Journal of Pediatric Gastroenterology and Nutrition, vol. 70, no. 1, pp. 141–156, 2020, doi: 10.1097/MPG.0000000000002497.
[9] A. Al-Toma, U. Volta, and R. Auricchio, ‘European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders’, United European Gastroenterology Journal, vol. 7, no. 5, pp. 583–613, 2019, doi: 10.1177/2050640619844125.
[10] H. A. Hamamy, L. A. Jamhawi, J. A. Al-Darawsheh, and K. Ajlouni, ‘Consanguineous marriages in Jordan: why is the rate changing with time?’, Clinical Genetics, vol. 67, no. 6, pp. 511–516, 2007, doi: 10.1111/j.1399-0004.2005.00426.x.
[11] B. Lebwohl, D. S. Sanders, and P. H. R. Green, ‘Coeliac disease’, Lancet, vol. 391, no. 10115, pp. 70–81, 2018, doi: 10.1016/S0140-6736(17)31796-8.
[12] B. Meresse, G. Malamut, and N. Cerf-Bensussan, ‘Celiac disease: an immunological jigsaw’, Immunity, vol. 36, no. 6, pp. 907–919, 2012, doi: 10.1016/j.immuni.2012.06.006.
[13] B. Zanini, F. Caselani, and A. Magni, ‘Celiac disease with mild enteropathy is not mild disease’, Clinical Gastroenterology and Hepatology, vol. 11, no. 3, pp. 253–258, 2013, doi: 10.1016/j.cgh.2012.11.010.
[14] P. H. R. Green and C. Cellier, ‘Celiac disease’, New England Journal of Medicine, vol. 357, no. 17, pp. 1731–1743, 2007, doi: 10.1056/NEJMra071600.
[15] A. Fasano and C. Catassi, ‘Celiac disease’, New England Journal of Medicine, vol. 367, no. 25, pp. 2419–2426, 2012, doi: 10.1056/NEJMcp1113994.
[16] A. Rubio-Tapia, I. D. Hill, C. P. Kelly, A. H. Calderwood, and J. A. Murray, ‘ACG clinical guidelines: diagnosis and management of celiac disease’, American Journal of Gastroenterology, vol. 108, no. 5, pp. 656–676, 2013, doi: 10.1038/ajg.2013.79.

